International Review of Ophthalmology

Previous Articles     Next Articles

Treatment progress of central serous chorioretinopathy

YAO Mu-di, ZHANG Xiao-pei, YAO Jin   

  1. Eye Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2018-03-06 Online:2018-04-22 Published:2018-05-04
  • Contact: YAO Jin, dryaojin@vip.sina.com
  • Supported by:

    National Natural Science Foundation of China(81670878)

Abstract:

Central serous chorioretinopathy (CSCR) is a self-limiting disease characterized by serous retinal detachment, and choroid and retinal pigment epithelium (RPE) dysfunction. Most of acute and chronic CSCR require treatment. At present, the main treatment methods include laser, surgery, medicine and gene therapy. (Int Rev Ophthalmol, 2018, 42: 107-110)